Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gang Lin

Showing results (361-370 of 379) with videos related to

Pageof 38
Sort By:
Journal of the National Cancer Institute|October 3, 2002
Randomized trial of breast self-examination in Shanghai: final resultsDavid B Thomas, Dao Li Gao, Roberta M Ray, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in miceEsilida Sula Karreci, Hao Fan, Mayuko Uehara, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 25, 2005
[Randomized trial of breast self-examination in 266,064 women in Shanghai]Dao-li Gao, David B Thomas, Roberta M Ray, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome InhibitorsShreeya Garg, Oriana Kreutzfeld, Sevil Chelebieva, et al.
BMC Cancer|August 10, 2022
Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control studyEmma Fontvieille, Mathilde His, Carine Biessy, et al.
Journal of Medicinal Chemistry|June 11, 2019
Improvement of Asparagine Ethylenediamines as Anti-malarial <i>Plasmodium</i>-Selective Proteasome InhibitorsWenhu Zhan, Joseph Visone, Tierra Ouellette, et al.
Cell Chemical Biology|May 6, 2023
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistanceWenhu Zhan, Daqiang Li, Shubha Bevkal Subramanyaswamy, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Biomedical and Environmental Sciences : BES|November 6, 2023
Treatment Outcomes in COVID-19 Patients with Brucellosis: Case Series in Heilongjiang and Systematic Review of LiteratureMan Li Yang, Jing Ya Wang, Xing Yu Zong, et al.
Pageof 38

Showing results (361-370 of 379) with videos related to

Sort By:
Pageof 38
Journal of the National Cancer Institute|October 3, 2002
Randomized trial of breast self-examination in Shanghai: final resultsDavid B Thomas, Dao Li Gao, Roberta M Ray, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in miceEsilida Sula Karreci, Hao Fan, Mayuko Uehara, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 25, 2005
[Randomized trial of breast self-examination in 266,064 women in Shanghai]Dao-li Gao, David B Thomas, Roberta M Ray, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome InhibitorsShreeya Garg, Oriana Kreutzfeld, Sevil Chelebieva, et al.
BMC Cancer|August 10, 2022
Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control studyEmma Fontvieille, Mathilde His, Carine Biessy, et al.
Journal of Medicinal Chemistry|June 11, 2019
Improvement of Asparagine Ethylenediamines as Anti-malarial <i>Plasmodium</i>-Selective Proteasome InhibitorsWenhu Zhan, Joseph Visone, Tierra Ouellette, et al.
Cell Chemical Biology|May 6, 2023
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistanceWenhu Zhan, Daqiang Li, Shubha Bevkal Subramanyaswamy, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Biomedical and Environmental Sciences : BES|November 6, 2023
Treatment Outcomes in COVID-19 Patients with Brucellosis: Case Series in Heilongjiang and Systematic Review of LiteratureMan Li Yang, Jing Ya Wang, Xing Yu Zong, et al.
Pageof 38